Property investors and manager Dexus (ASX:DXS) have issued a warning to investors, indicating that they can anticipate reduced returns in the fiscal year 2023-24. This caution follows an annual loss reported by the real estate firm for the period ending on June 30. The decline in values of CBD buildings has significantly impacted the company’s […]
Lower returns expected for property investors Read More »
16 Aug 2023 – A snapshot of the stocks on the move, featuring AML3D (ASX:AL3), Imugene (ASX:IMU) and Loyal Lithium (ASX:LLI).
Stocks of the Hour: AML3D, Imugene, Loyal Lithium Read More »
Investing in infrastructure can deliver downside protection, inflation protection and diversification. Tim Humphreys, Head of Global Listed Infrastructure at Ausbil Investment Management, discusses the asset class and opportunities in the short and medium term. Paul Sanger: Hi. I’m Paul Sanger from the Finance News Network, and today we’re interviewing Tim Humphreys, who is the Portfolio
Investing in essential infrastructure Read More »
China’s shift towards deflation is causing concern in financial markets, yet some money managers suggest potential positive outcomes, as lower prices stemming from China’s role as a major global producer could lead to reduced costs worldwide. This deflationary trend might enable central banks to avoid further interest rate hikes, potentially pivoting towards easing to support
ASX down 1.31% as China’s deflation concerns spooks investors Read More »
AML3D (ASX:AL3) has received a $2M order from US Navy for submarine parts. In response, interim CEO Sean Ebert said: “AML3D’s focus is on the US defence, aviation and maritime sectors and the company is well positioned to access the many opportunities that will be created as a result of the AUKUS Alliance, in the
Stocks of the Hour: AML3D, Imugene, Loyal Lithium Read More »
16 Aug 2023 – Mark Leong – Executive Chairman – Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
Osteopore (ASX:OSX) – TechKnow Invest Roadshow, August 2023 Read More »
Brad Gurrie – CEO – Socialsuite is a global Software-as-a-Service (SaaS) enterprise, leading the industry in offering solutions for Environmental, Social, and Governance reporting and outcomes measurement.
Socialsuite – TechKnow Invest Roadshow, August 2023 Read More »
Nicholas Pollock – CEO – K2fly (ASX:K2F) delivers resource governance software and services to Tier 1 clients working in the asset-intensive sectors of mining, utilities, oil and gas, and rail.
K2fly (ASX:K2F) – TechKnow Invest Roadshow, August 2023 Read More »
Tom Spurling – Executive Director – Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.
Nova Eye Medical (ASX:EYE) – TechKnow Invest Roadshow, August 2023 Read More »
Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Prescient Therapeutics (ASX:PTX) – TechKnow Invest Roadshow, August 2023 Read More »
